NEUROVANCE

neurovance-logo

Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD. Neurovance has been funded in a venture capital investment by Novartis Venture Fund, Venture Investors, Tekla Capital Management, GBS Venture Partners, State of Wisconsin Investment Board (SWIB), and Timothy J. Barberich. It was founded in 2009 and is headquartered in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

NEUROVANCE

Industry:
Biotechnology Clinical Trials Health Care Neuroscience

Founded:
2009-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.neurovance.com

Total Employee:
1+

Status:
Closed

Contact:
(617) 758-0300

Email Addresses:
[email protected]

Total Funding:
31.78 M USD

Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Symantec Secure Site Citrix NetScaler Register.com DNS Confluence Networks


Similar Organizations

alphamab-oncology-logo

Alphamab Oncology

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.

good-start-genetics-logo

Good Start Genetics

Good Start Genetics is a molecular genetic information company that has designed a proprietary tech platform to harness the power of NGS.

minerva-neuroscience-logo

Minerva Neuroscience

Minerva Neurosciences is a clinical-stage biopharmaceutical company

novaseek-research-logo

Novaseek Research

Novaseek Research is a clinical data analytics and biospecimen sourcing, has developed a clinical data network platform for research.

prothena-logo

Prothena

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

vbi-vaccines-logo

VBI Vaccines

VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.


Current Advisors List

paul-weiss_image

Paul Weiss Member of the Board of Directors @ Neurovance
Board_member

joshua-funder_image

Joshua Funder Member of the Board of Directors @ Neurovance
Board_member

frank-t-gentile_image

Frank T. Gentile Member of the Board of Directors @ Neurovance
Board_member

timothy-j-barberich_image

Timothy J. Barberich Member of the Board of Directors @ Neurovance
Board_member
2010-01-01

Current Employees Featured

franklin-p-bymaster_image

Franklin P. Bymaster
Franklin P. Bymaster Co-Founder & Chief Scientific Officer @ Neurovance
Co-Founder & Chief Scientific Officer
2009-01-01

Founder


anthony-a-mckinney_image

Anthony A. McKinney

franklin-p-bymaster_image

Franklin P. Bymaster

Investors List

venture-investors_image

Venture Investors

Venture Investors investment in Series A - Neurovance

venture-investors_image

Venture Investors

Venture Investors investment in Series A - Neurovance

timothy-j-barberich_image

Timothy J. Barberich

Timothy J. Barberich investment in Series A - Neurovance

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Series A - Neurovance

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Neurovance

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series A - Neurovance

h-q-healthcare-investors_image

H&Q Healthcare Investors

H&Q Healthcare Investors investment in Series A - Neurovance

state-of-wisconsin-investment-board_image

State of Wisconsin Investment Board

State of Wisconsin Investment Board investment in Series A - Neurovance

state-of-wisconsin-investment-board_image

State of Wisconsin Investment Board

State of Wisconsin Investment Board investment in Venture Round - Neurovance

gbs-ventures_image

GBS Ventures

GBS Ventures investment in Venture Round - Neurovance

Official Site Inspections

http://www.neurovance.com

  • Host name: ec2-54-84-220-185.compute-1.amazonaws.com
  • IP address: 54.84.220.185
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Neurovance" on Search Engine